Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Bone Biologics (BBLGW) Debt Ratio (2016 - 2017)

Bone Biologics (BBLGW) has disclosed Debt Ratio for 2 consecutive years, with 12.05 as the latest value for Q3 2017.

  • Quarterly Debt Ratio fell 37.89% to 12.05 in Q3 2017 from the year-ago period, while the trailing twelve-month figure was 12.05 through Sep 2017, down 37.89% year-over-year, with the annual reading at 12.5 for FY2016, N/A changed from the prior year.
  • Debt Ratio for Q3 2017 was 12.05 at Bone Biologics, down from 21.98 in the prior quarter.
  • The five-year high for Debt Ratio was 21.98 in Q2 2017, with the low at 3.32 in Q1 2016.